ArticleSpine surgery and related research2026
Prognostic Accuracy of Eight Scoring Systems in Untreated Patients with Spinal Metastases: A Comparative Study.
Article in Spine surgery and related research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To compare the prognostic accuracy of eight widely used scoring systems and their Primary Tumor-Independent (PTI) versions in untreated patients with spinal metastases (SPM). Methods: Data from 108 untreated patients with SPM diagnosed between 2017 and 2023 were retrospectively analyzed. Prognostic accuracy was assessed for eight scoring systems: Skeletal Oncology Research Group (SORG) Nomogram, New Katagiri score, Revised Tokuhashi Score, Tomita Score, New England Metastatic Spinal Score, Modified Bauer Score, Oswestry Spinal Risk Index, and van der Linden Score. PTI versions were also evaluated by excluding primary tumor information. Predictive accuracy was assessed using receiver operating characteristic analysis at 90 days, 180 days, and 1 year. Results: At 90 days, the New Katagiri score demonstrated the highest predictive accuracy (area under the curve [AUC]=0.788). The SORG Nomogram exhibited the highest accuracy at 180 days (AUC=0.759) and 1 year (AUC=0.749). In PTI analysis, the SORG Nomogram-PTI retained the highest accuracy at 90 days (AUC=0.728) and 180 days (AUC=0.719). Conclusions: The New Katagiri score and the SORG Nomogram demonstrated high prognostic accuracy for untreated SPM patients, with the SORG Nomogram-PTI maintaining strong predictive performance even without primary tumor information. These scoring systems are valuable tools for survival estimation and clinical decision-making in this challenging patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.